Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Public biotechnology 2003—the numbers

Nature Biotechnology's annual survey of public biotechnology companies finds some attrition, but on the whole a stronger sector.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Van Brunt, J. Financing finally flows. Signals Magazine, Jan. 2004, http://www.signalsmag.com/signalsmag.nsf/.

  2. Burrill, G.S. Biotech 2004: Back on Track (Burrill & Company, San Francisco, CA, 2004).

    Google Scholar 

  3. Ernst & Young. Refocus: The European Perspective Global Biotechnology Report 2004 (UK Health Sciences Group, Ernst & Young, Reading, UK, 2004).

  4. Lähteenmäki, R. & DeFrancesco, L. Public biotechnology 2002—the numbers. Nat. Biotechnol. 21, 607–612 (2003).

    Article  Google Scholar 

  5. Louët, S. IPO floodgates unlikely to open after Ark flotation. Nat. Biotechnol. 22, 367–368 (2004).

    Article  Google Scholar 

  6. Kandachi, K. Japan's biotech sector shows signs of life. Nat. Biotechnol. 21, 1256–1257 (2003).

    Article  CAS  Google Scholar 

  7. Bouchie, A. Companies jostle for access to public markets. Nat. Biotechnol. 21, 1413–1414 (2003).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Riku Lähteenmäki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lähteenmäki, R., Baker, M. Public biotechnology 2003—the numbers. Nat Biotechnol 22, 665–670 (2004). https://doi.org/10.1038/nbt0604-665

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0604-665

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing